The sexual long COVID (SLC): erectile dysfunction as a biomarker of systemic complications for COVID-19 long haulers
A Sansone, D Mollaioli, E Limoncin… - Sexual Medicine …, 2022 - academic.oup.com
Introduction Long term complications of COVID-19, the disease caused by the SARS-CoV-2,
involve many organ systems, dramatically worsening the quality of life, and finally …
involve many organ systems, dramatically worsening the quality of life, and finally …
Targeting the 26S proteasome to protect against proteotoxic diseases
Aggregates of misfolded proteins can compromise the function of the 26S proteasome
complex, leaving neurons susceptible to accelerated and impaired protein homeostasis …
complex, leaving neurons susceptible to accelerated and impaired protein homeostasis …
Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat
MG Ferrini, I Kovanecz, S Sanchez… - Biology of …, 2007 - academic.oup.com
Aging-related erectile dysfunction is characterized by a loss of smooth muscle cells (SMCs)
and fibrosis in the corpora cavernosa, and functionally by corporal veno-occlusive …
and fibrosis in the corpora cavernosa, and functionally by corporal veno-occlusive …
Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a …
S Limoncella, C Lazzaretti, E Paradiso… - Molecular and cellular …, 2022 - Elsevier
Abstract Type 5 phosphodiesterase (PDE5) blockade by inhibitors (PDE5i) results in
intracellular cyclic guanosine monophosphate (cGMP) increase and smooth muscle …
intracellular cyclic guanosine monophosphate (cGMP) increase and smooth muscle …
Prostacyclin analogues inhibit platelet reactivity, extracellular vesicle release and thrombus formation in patients with pulmonary arterial hypertension
A Gąsecka, M Banaszkiewicz, R Nieuwland… - Journal of Clinical …, 2021 - mdpi.com
(1) Background: Prostacyclin analogues (epoprostenol, treprostinil, and iloprost) induce
vasodilation in pulmonary arterial hypertension (PAH) but also inhibit platelet function.(2) …
vasodilation in pulmonary arterial hypertension (PAH) but also inhibit platelet function.(2) …
Drug-induced thrombosis: an update
Y Ramot, A Nyska, G Spectre - Drug safety, 2013 - Springer
Drugs may play an important role in development of thrombosis, and in recent years there
has been increased attention to the importance of this issue. Although drug-induced …
has been increased attention to the importance of this issue. Although drug-induced …
Effects of phosphodiesterase type 5 inhibitors on choroid and ocular vasculature: a literature review
NFS da Cruz, MU Polizelli, LM Cezar… - International Journal of …, 2020 - Springer
To provide information on the effects of phosphodiesterase type 5 (PDE5) inhibitors on
choroidal vessels and central serous chorioretinopathy (CSC) and possible implications for …
choroidal vessels and central serous chorioretinopathy (CSC) and possible implications for …
Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects
C Foresta, N Caretta, D Zuccarello, A Poletti, A Biagioli… - Eye, 2008 - nature.com
Objective We tested the effect of two phosphodiesterase type-5 (PDE5) inhibitors, sildenafil
and tadalafil, on ophthalmic artery (OA) blood flow velocity and investigated the presence of …
and tadalafil, on ophthalmic artery (OA) blood flow velocity and investigated the presence of …
A gas chromatography/mass spectrometry method for the determination of sildenafil, vardenafil and tadalafil and their metabolites in human urine
S Strano‐Rossi, L Anzillotti… - … in Mass Spectrometry, 2010 - Wiley Online Library
Abstract Sildenafil (SDF), vardenafil (VDF) and tadalafil (TDF) are phosphodiesterase type 5
enzyme inhibitors (PDE5Is), used in the treatment of erectile disorders and to improve …
enzyme inhibitors (PDE5Is), used in the treatment of erectile disorders and to improve …
Effects of sildenafil and tadalafil on ischemia/reperfusion injury in fetal rat brain
O Ozdegirmenci, T Kucukozkan, E Akdag… - The Journal of …, 2011 - Taylor & Francis
Objective. The aim of the present study was to evaluate the effects of phosphodiesterase
type 5 (PDE5) inhibitory drugs, sildenafil and tadalafil, in ischemia/reperfusion (I/R)-induced …
type 5 (PDE5) inhibitory drugs, sildenafil and tadalafil, in ischemia/reperfusion (I/R)-induced …